Clinical Trials Logo

Clinical Trial Summary

The purpose of this research is to identify the New Psychoactive Substances (NPS) that are responsible for intoxicating patients in ski resort during winter activities.


Clinical Trial Description

The New Psychoactive Substances expose to an additional risk of overdose or death due to their potency. These New Psychoactive Substances are used voluntarily by users wishing to test new substances, but also involuntarily because of association (unknowingly users) with more "conventional" drugs such as cocaine or heroin in the self-administered powder. These intoxications are still poorly known and the investigators believe that the identification of New Psychoactive Substances among the drugs consumed, and the association of their consumption with the appearance of a particular symptomatology allow the physician to guide the diagnosis and facilitate the care of future patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04155281
Study type Observational
Source University Hospital, Grenoble
Contact
Status Completed
Phase
Start date January 23, 2020
Completion date October 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04957628 - AlcoTail - Implementation of Tailored Interventions
Not yet recruiting NCT05505188 - Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer N/A
Terminated NCT03449771 - PrEP and Consumptions N/A